دورية أكاديمية
أعرض في EDS

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values.

التفاصيل البيبلوغرافية
العنوان: Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values.
المؤلفون: Melhem MSC; Mycology Unit, Parasitology and Mycology Department, Instituto Adolfo Lutz, Secretary of Health, Government of São Paulo State, São Paulo 01246-902, SP, Brazil.; Graduate Program in Sciences, Coordination of Diseases Control, Secretary of Health, Government of São Paulo State, São Paulo 01246-902, SP, Brazil.; Graduate Program in Infectious and Parasitic Diseases, Faculdade de Medicina, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil., Coelho VC; Laboratório de Investigação Médica em Imunologia (LIM 48), Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Fonseca CA; Laboratório de Investigação Médica em Imunologia (LIM 48), Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Oliveira L; Mycology Unit, Parasitology and Mycology Department, Instituto Adolfo Lutz, Secretary of Health, Government of São Paulo State, São Paulo 01246-902, SP, Brazil., Bonfietti LX; Mycology Unit, Parasitology and Mycology Department, Instituto Adolfo Lutz, Secretary of Health, Government of São Paulo State, São Paulo 01246-902, SP, Brazil., Szeszs MW; Mycology Unit, Parasitology and Mycology Department, Instituto Adolfo Lutz, Secretary of Health, Government of São Paulo State, São Paulo 01246-902, SP, Brazil., Magri MMC; Laboratório de Investigação Médica em Imunologia (LIM 48), Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil.; Division of Infectious Diseases, Hospital das Clínicas da Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Dorneles FS; Graduate Program in Infectious and Parasitic Diseases, Faculdade de Medicina, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil., Taguchi H; Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan., Moreira DVS; Laboratório de Investigação Médica em Imunologia (LIM 48), Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Motta AL; Laboratory of Microbiology, Division of Central Laboratory-Laboratory of Medical Investigation-LIM 03, Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Batista MV; Division of Infectious Diseases, Hospital das Clínicas da Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil., Kamei K; Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan., Shikanai-Yasuda MA; Laboratório de Investigação Médica em Imunologia (LIM 48), Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil.; Department of Infectious and Parasitic Diseases, Faculdade de Medicina, University of São Paulo, São Paulo 05403-000, SP, Brazil.
المصدر: Pharmaceutics [Pharmaceutics] 2022 Oct 11; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 11.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time-consuming and technically complex reference methodologies. The Sensititre YeastOne (SYO) and Etest methods are widely utilized for yeasts but have not been extensively evaluated for Aspergillus isolates. We obtained Posaconazole (POS), Voriconazole (VCZ), Itraconazole (ITC), Amphotericin B (AMB), Caspofungin (CAS), and Anidulafungin (AND) minimum inhibitory concentrations (MICs) for both the Etest (n = 330) and SYO (n = 339) methods for 106 sequenced clinical strains. For 84 A. fumigatus, we analyzed the performance of both commercial methods in comparison with the CLSI-AFST, using available cutoff values. An excellent correlation could be demonstrated for Etest-AMB and Etest-VCZ (p < 0.01). SYO-MICs of AMB, VCZ, and POS resulted in excellent essential agreement (>93%), and >80% for AMB, VCZ, and ITC Etest-MICs. High categoric agreement was found for AMB, ITC, and CAS Etest-MICs (>85%) and AMB SYO-MICs (>90%). The considerable number of major/very major errors found using Etest and SYO, possibly related to the proposed cutoffs and associated with the less time-consuming processes, support the need for the improvement of commercial methods for Aspergillus strains.
References: J Fungi (Basel). 2022 Mar 17;8(3):. (PMID: 35330310)
Antimicrob Agents Chemother. 2020 Feb 21;64(3):. (PMID: 31844011)
J Clin Microbiol. 2015 Oct;53(10):3176-81. (PMID: 26202113)
Diagn Microbiol Infect Dis. 2006 Sep;56(1):53-5. (PMID: 16650953)
Open Forum Infect Dis. 2021 Sep 09;8(11):ofab444. (PMID: 34778489)
Antimicrob Agents Chemother. 2018 Mar 27;62(4):. (PMID: 29437624)
J Clin Microbiol. 2007 Jun;45(6):2000-1. (PMID: 17428931)
J Clin Microbiol. 2017 Jun;55(6):1714-1719. (PMID: 28330883)
Curr Fungal Infect Rep. 2020 Jun;14(2):141-152. (PMID: 32699568)
J Antimicrob Chemother. 2003 Sep;52(3):365-70. (PMID: 12917236)
Int J Syst Evol Microbiol. 2006 Feb;56(Pt 2):477-486. (PMID: 16449461)
J Fungi (Basel). 2018 Sep 15;4(3):. (PMID: 30223554)
Antimicrob Agents Chemother. 2017 May 24;61(6):. (PMID: 28416538)
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. (PMID: 33333012)
J Fungi (Basel). 2019 Nov 22;5(4):. (PMID: 31766762)
Antimicrob Agents Chemother. 2018 Dec 21;63(1):. (PMID: 30323038)
Antimicrob Agents Chemother. 2011 Aug;55(8):3944-6. (PMID: 21670187)
J Clin Microbiol. 2002 Jun;40(6):2101-7. (PMID: 12037072)
Future Microbiol. 2014;9(8):947-67. (PMID: 25302953)
Mycoses. 2010 Jan;53(1):1-11. (PMID: 20078786)
J Clin Microbiol. 2003 Nov;41(11):5270-2. (PMID: 14605181)
Front Cell Infect Microbiol. 2021 Sep 10;11:720609. (PMID: 34568095)
Appl Environ Microbiol. 1995 Apr;61(4):1323-30. (PMID: 7747954)
Mycopathologia. 2014 Apr;177(3-4):157-66. (PMID: 24570038)
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0109321. (PMID: 34370582)
PLoS One. 2016 Oct 3;11(10):e0163919. (PMID: 27695080)
Mycopathologia. 2018 Apr;183(2):359-370. (PMID: 28994001)
J Clin Microbiol. 2001 Apr;39(4):1360-7. (PMID: 11283057)
J Clin Microbiol. 2018 Sep 25;56(10):. (PMID: 30093391)
J Clin Microbiol. 2002 Aug;40(8):2876-85. (PMID: 12149345)
Eukaryot Cell. 2006 Oct;5(10):1705-12. (PMID: 17030996)
J Clin Microbiol. 2006 Oct;44(10):3616-22. (PMID: 16943356)
Rev Iberoam Micol. 2016 Apr-Jun;33(2):63-75. (PMID: 27296911)
Clin Microbiol Rev. 2020 Apr 29;33(3):. (PMID: 32349998)
Intensive Care Med. 2007 Oct;33(10):1694-703. (PMID: 17646966)
Clin Microbiol Infect. 2019 Dec;25(12):1546-1552. (PMID: 31082487)
Expert Rev Anti Infect Ther. 2011 Mar;9(3):307-15. (PMID: 21417870)
فهرسة مساهمة: Keywords: Aspergillus fumigatus; CLSI; Etest; Sensititre YeastOne; azole antifungals; gradient diffusion assays
تواريخ الأحداث: Date Created: 20221027 Latest Revision: 20230308
رمز التحديث: 20230309
مُعرف محوري في PubMed: PMC9607534
DOI: 10.3390/pharmaceutics14102161
PMID: 36297597
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4923
DOI:10.3390/pharmaceutics14102161